Efficacy and Safety of Olmesartan Associated With Chlorthalidone in Essential Arterial Hypertension Control

NCT02493322 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Decided by Sponsor

Conditions

Essential Arterial Hypertension

Interventions

DRUG: Olmesartan Medoxomil 20mg + Chlorthalidone 12,5mg
DRUG: Olmesartan medoxomil 20mg + Chlortalidone 25mg
DRUG: Olmesartan 20mg + hydrochlorothiazide 12,5mg

Sponsor

EMS